Immunotherapy
226533
225502722
2008-07-14T01:06:47Z
206.188.63.30
/* Latest research */
{{Copyedit|date=September 2007}}
{{Refimprove|date=June 2007}}
'''Immunotherapy,''' in medicine, refers to an array of treatment strategies based upon the concept of modulating the [[immune system]] to achieve a [[Prophylaxis|prophylactic]] and/or [[Immunosuppressive therapy|therapeutic]] goal.
==Activation==
===Cancer===
[[Cancer immunotherapy]] attempts to stimulate the [[immune system]] to reject and destroy tumors. [[Bacillus Calmette-Guérin|BCG]] immunotherapy for early stage (non-invasive) [[bladder cancer]] utilizes ''instillation'' of attenuated live bacteria into the bladder, and is effective in preventing recurrence in up to two thirds of cases. Topical immunotherapy utilizes an immune enhancement cream ([[imiquimod]]) which is an interferon producer causing the patients own killer T cells to destroy warts, actinic keratoses, basal cell cancer, squamous cell cancer, cutaneous lymphoma, and superficial malignant melanoma. Injection immunotherapy uses mumps, candida or trichophytin antigen injections to treat warts (HPV induced tumors).
====Dendritic cell based immunotherapy====
This utilizes [[dendritic cells]] to activate a [[cytotoxic]] response towards an [[antigen]]. Dendritic cells, an [[antigen presenting cell]], are harvested from a patient. These cells are then either pulsed with an antigen or transfected with a [[viral vector]]. The activated dendritic cells are then placed back into the patient; these cells then present the antigens to effector lymphocytes (CD4+ T cells, CD8+ T cells, and in specialized dendritic cells, B cells also). This initiates a cytotoxic response to occur against these antigens and anything that may present these antigens. One use for this therapy is in cancer immunotherapy. Tumor Antigens are presented to dendritic cells, which cause the immune system to target these antigens, which are often expressed on cancerous cells.
====T cell based adoptive immunotherapy====
This therapy uses T cell-based cytotoxic responses to attack cancer. In brief, T cells that have a natural or genetically engineered reactivity to a patients' cancer are expanded ''in vitro'' using a variety of means and then adoptively transferred into a cancer patient. T cells with a natural occurring reactivity to a patient’s cancer can be found infiltrated in the patients' own tumors. The tumor is harvested, and these tumor infiltrating lymphocytes (TIL) are expanded ''in vitro'' using high concentrations of interluekin-2 (IL-2), anti-CD3 and allo-reactive feeders. These T cells are then transferred back into the patient along with exogenous administration of IL-2. Thus far, a 51% objective response rate has been observed; in some patients, tumors shrank to indetectable size. In the case of engineered T cells, T cell receptors (TCR) that have been identified to have reactivity against tumor associated antigens are cloned into a replication incompetent virus that is capable of genomic integration. A patients own lymphocytes are exposed to these viruses and then expanded non-specifically or stimulated using the engineered TCR. The cells are then transferred back into the patient. This therapy has been demonstrated to result in objective clinical responses in patients with refractory stage IV cancer. The Surgery Branch of the National Cancer Institute (Bethesda, Maryland) is actively investigating this form of cancer treatment for patients suffering aggressive melanomas.
===Vaccination===
[[Anti-microbial]] immunotherapy, which includes [[vaccination]], involves activating the [[immune system]] to respond to an infectious agent.
==Suppression==
[[Immune suppression]] dampens an abnormal [[immune response]] in [[autoimmune diseases]] or reduces a normal [[immune response]] to prevent [[transplant rejection|rejection]] of [[Organ transplant|transplanted]] organs or cells.
===Immune tolerance===
<!-- "Immune tolerance therapies" does such a concept exist -->
[[Immune tolerance]] is the process by which the body naturally does not launch an immune system attack on its own tissues. Immune tolerance therapies seeks to reset the immune system so that the body stops mistakenly attacking its own organs or cells in [[autoimmune disease]] or accepts foreign tissue in [[organ transplant]]ation.<ref name="pmid12110811">{{cite journal |author=Rotrosen D, Matthews JB, Bluestone JA |title=The immune tolerance network: a new paradigm for developing tolerance-inducing therapies |journal=J. Allergy Clin. Immunol. |volume=110 |issue=1 |pages=17–23 |year=2002 |pmid=12110811|doi=10.1067/mai.2002.124258}}</ref> A brief treatment should then reduce or eliminate the need for life-long immunosuppression and the chances of attendant side effects, in the case of transplantation, or preserve the body's own function, at least in part, in cases of type 1 diabetes or other autoimmune disorders.
===Allergies===
{{main|Allergy immunotherapy}}
Immunotherapy is also used to treat [[allergy|allergies]]. While other allergy treatments (such as [[antihistamine]]s or [[corticosteroids]]) treat only the symptoms of allergic disease, immunotherapy is the only available treatment that can modify the natural course of the allergic disease, by reducing sensitivity to [[allergen]]s.
A three-to-five-year individually tailored regimen of injections may result in long-term benefits. Recent research suggests that patients who complete immunotherapy may continue to see benefits for years to come.<ref name="pmid10441602">{{cite journal |author=Durham SR, Walker SM, Varga EM, ''et al'' |title=Long-term clinical efficacy of grass-pollen immunotherapy |journal=N. Engl. J. Med. |volume=341 |issue=7 |pages=468–75 |year=1999 |pmid=10441602|doi=10.1056/NEJM199908123410702}}</ref> Immunotherapy does not work for everyone and is only partly effective in some people, but it offers allergy sufferers the chance to eventually reduce or stop symptomatic/rescue medication.
The therapy is indicated for people who are extremely allergic or who cannot avoid specific [[allergen]]s. For example, they may not be able to live a normal life and completely avoid pollen, dust mites, mold spores, pet dander, insect venom, and certain other common triggers of allergic reactions. Immunotherapy is generally not indicated for food or medicinal allergies. Immunotherapy is typically individually tailored and administered by an allergist (allergologist). Injection schedules are available in some healthcare systems and can be prescribed by family physicians. This therapy is particularly useful for people with [[allergic rhinitis]] or [[asthma]].
The therapy is particularly likely to be successful if it begins early in life or soon after the allergy develops for the first time. Immunotherapy involves a series of injections (shots) given regularly for several years by a specialist in a hospital clinic. In the past, this was called a serum, but this is an incorrect name. Most allergists now call this mixture an allergy extract. The first shots contain very tiny amounts of the allergen or antigen to which you are allergic. With progressively increasing dosages over time, your body will adjust to the allergen and become less sensitive to it. This process is called desensitization. A recently approved sublingual tablet ([[Grazax]]), containing a grass pollen extract, is similarly effective, with few side effects, and can be self-administered at home, including by those patients who also suffer from allergic asthma, a condition which precludes the use of injection-based desensitization. To read more about this topic, see: [[allergy]] and [[hyposensitization]].
==Latest research==
In June 2008, it was announced that [[US]] doctors from the Clinical Research Division led by Dr. Cassian Yee at [[Fred Hutchinson Cancer Research Center]] in [[Seattle]] have for the first time successfully treated a [[skin cancer]] patient by using [[immune cells]] [[cloned]] from his own [[immune system]] which were then re-injected into him. The patient, who was suffering from advanced skin cancer, was free from tumours within eight weeks of being injected with billions of his own immune cells in the first case of its kind. Experts say that this case could mark a landmark in the treatment of cancer in general. Larger trials are now under way. [http://www.telegraph.co.uk/earth/main.jhtml?xml=/earth/2008/06/18/scicanc118.xml] [http://www.breitbart.com/article.php?id=080618212711.38ht6zq0&show_article=1]
== See also ==
*[[American Cancer Society]]
*[http://www.isbtc.org/about/ International Society for Biological Therapy of Cancer]
==Footnotes==
<references/>
[[Category:Medical treatments]]
[[Category:Immunology]]
[[Category:camcer treatments]]
[[bg:Имунотерапия]]
[[de:Immuntherapie]]
[[es:Inmunoterapia]]
[[nl:Immunotherapie]]
[[ja:免疫療法]]
[[pl:Immunoterapia]]
[[sv:Immunotherapy]]